Business Context and Reporting Period
Company: InMed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 5, 2025
Reporting Period: Single event date (September 5, 2025)
Business Context: The filing serves as a Regulation FD disclosure announcing the company's participation in an upcoming investor conference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Event Announcement: InMed Pharmaceuticals will participate in the H.C. Wainwright 27th Annual Global Investment Conference.
- Event Dates: September 8-10, 2025.
- Location: New York.
- Activities: Management team will conduct one-on-one meetings with investors, and a corporate presentation will be available online.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and location of the H.C. Wainwright 27th Annual Global Investment Conference.
- Confirm the availability of the corporate presentation on the company's website or the conference portal.
- Review the content of the news release (Exhibit 99.1) for any additional details not summarized in the 8-K text.
- Check for subsequent filings if management provides updated guidance during the conference.